EyePoint, Inc. ($EYPT)
Filing Information
| Accession Number | 0002013623-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
302,807
Total Value
$111,400.04
P&L
+inf% (+$3,401,433.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 3, 2026 | Exercise/Conversion | 19,667 | $0.00 | $0.00 | 19,667 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 3, 2026 | Tax Withholding | 6,373 | $17.48 | $111,400.04 | 13,294 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Stock Units | Derivative | Jan 2, 2026 | Grant/Award | 85,700 | $0.00 | $0.00 | 85,700 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Grant/Award | 171,400 | $0.00 | $0.00 | 171,400 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Stock Units | Derivative | Jan 3, 2026 | Exercise/Conversion | 19,667 | $0.00 | $0.00 | 39,333 | Direct | โ | View Details |